No profile data available.
AlphaTON Capital Corp. (ATON) is a healthcare company in the additional cancer treatment drugs industry, based in Road Town, British Virgin Islands, with about 3 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$6.77 million. In Q2 2026 (the quarter ended September 30, 2025) revenue was $0. Its market capitalization was $13.04 million as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of December 4, 2025.
AlphaTON Capital Corp. operates as a digital asset treasury company. It focuses on building and managing a strategic reserve of The Open Network (TON) tokens and developing the Telegram ecosystem. The company provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform.
AlphaTON Capital reported $0 in revenue for fiscal year 2025. In Q2 2026 revenue was $0.
$13.04 million as of December 4, 2025.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include Pasithea Therapeutics Corp. (KTTA), TScan Therapeutics, Inc. (TCRX), Actuate Therapeutics, Inc. Common stock (ACTU), Tempest Therapeutics, Inc. (TPST).